GEN Exclusives

More »

GEN News Highlights

More »
Aug 9, 2007

Lilly Facility Expansion Inaugurated in Puerto Rico

  • Puerto Rico Governor Aníbal Acevedo Vilá inaugurated the new expansion facility of Lilly del Caribe, a subsidiary of Eli Lilly. The new plant will manufacture the active ingredient in Cymbalta, an antidepressant, and Cialis, which competes with Pfizer's Viagra. Cymbalta, a competitor of the company's own Prozac,  is expected to be one of the main products in Lilly del Caribe’s portfolio.

    The new facility comprises over 230,000 sq. ft. and brings with it an investment of over $150 million and the creation of more than 250 new jobs, according to the governor’s office.

    Since 2001, Lilly del Caribe has invested over $1.2 billion in Puerto Rico, according to Eli Lilly. The company employs more than 1,700 people in manufacturing, sales, and marketing and contributes more than $358 million to the island’s economy, notes Governor Acevedo Vilá.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »